These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 14713326)

  • 1. Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy.
    Mansky PJ; Grem J; Wallerstedt DB; Monahan BP; Blackman MR
    Integr Cancer Ther; 2003 Dec; 2(4):345-52. PubMed ID: 14713326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mistletoe therapy: friend or foe in established anti-tumor protocols? A multicenter, controlled, retrospective pharmaco-epidemiological study in pancreas cancer.
    Matthes H; Friedel WE; Bock PR; Zänker KS
    Curr Mol Med; 2010 Jun; 10(4):430-9. PubMed ID: 20455850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intratumoral Mistletoe (Viscum album L) Therapy in Patients With Unresectable Pancreas Carcinoma: A Retrospective Analysis.
    Schad F; Atxner J; Buchwald D; Happe A; Popp S; Kröz M; Matthes H
    Integr Cancer Ther; 2014 Jul; 13(4):332-40. PubMed ID: 24363283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of standardized mistletoe (Viscum album) extracts with chemotherapeutic drugs regarding cytostatic and cytotoxic effects in vitro.
    Weissenstein U; Kunz M; Urech K; Baumgartner S
    BMC Complement Altern Med; 2014 Jan; 14():6. PubMed ID: 24397864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patients are talking about ... Iscador (mistletoe).
    Decker G
    Clin J Oncol Nurs; 2001; 5(4):183-4. PubMed ID: 12690624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mistletoe: for cancer or just for Christmas?
    de Giorgio A; Stebbing J
    Lancet Oncol; 2013 Dec; 14(13):1264-5. PubMed ID: 24275128
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunomodulatory effects of Viscum album extracts on natural killer cells: review of clinical trials.
    Braedel-Ruoff S
    Forsch Komplementmed; 2010 Apr; 17(2):63-73. PubMed ID: 20484913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use and safety of intratumoral application of European mistletoe (Viscum album L) preparations in Oncology.
    Steele ML; Axtner J; Happe A; Kröz M; Matthes H; Schad F
    Integr Cancer Ther; 2015 Mar; 14(2):140-8. PubMed ID: 25552476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of gemcitabine in non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group. Provincial Systemic Treatment Disease Site Group.
    Evans WK; Kocha W; Gagliardi A; Eady A; Newman TE
    Cancer Prev Control; 1999 Feb; 3(1):84-94. PubMed ID: 10474757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety of Combined Treatment With Monoclonal Antibodies and Viscum album L Preparations.
    Schad F; Axtner J; Kröz M; Matthes H; Steele ML
    Integr Cancer Ther; 2018 Mar; 17(1):41-51. PubMed ID: 29444603
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of mistletoe preparations (Viscum album) for patients with cancer diseases. A systematic review.
    Melzer J; Iten F; Hostanska K; Saller R
    Forsch Komplementmed; 2009 Aug; 16(4):217-26. PubMed ID: 19729932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementary Treatment with Mistletoe Extracts During Chemotherapy: Safety, Neutropenia, Fever, and Quality of Life Assessed in a Randomized Study.
    Pelzer F; Tröger W; Nat DR
    J Altern Complement Med; 2018; 24(9-10):954-961. PubMed ID: 30247950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Mistletoe (Viscum album) preparations: an optional drug for cancer patients?].
    Bar-Sela G; Gershony A; Haim N
    Harefuah; 2006 Jan; 145(1):42-6, 77. PubMed ID: 16450726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mistletoe in the treatment of cancer patients].
    Rostock M
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2020 May; 63(5):535-540. PubMed ID: 32211937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of gemcitabine in cancer therapy.
    Toschi L; Finocchiaro G; Bartolini S; Gioia V; Cappuzzo F
    Future Oncol; 2005 Feb; 1(1):7-17. PubMed ID: 16555971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mistletoe and cancer: controversies and perspectives.
    Mansky PJ
    Semin Oncol; 2002 Dec; 29(6):589-94. PubMed ID: 12516042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors.
    Dy GK; Suri A; Reid JM; Sloan JA; Pitot HC; Alberts SR; Goldberg RM; Atherton PJ; Hanson LJ; Burch PA; Rubin J; Erlichman C; Adjei AA
    Cancer Chemother Pharmacol; 2005 Jun; 55(6):522-30. PubMed ID: 15754203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of gemcitabine in non-small cell lung cancer: the Italian contribution.
    Metro G; Cappuzzo F; Finocchiaro G; Toschi L; Crinò L
    Ann Oncol; 2006 May; 17 Suppl 5():v37-46. PubMed ID: 16807461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical safety of combined therapy of immune checkpoint inhibitors and Viscum album L. therapy in patients with advanced or metastatic cancer.
    Thronicke A; Steele ML; Grah C; Matthes B; Schad F
    BMC Complement Altern Med; 2017 Dec; 17(1):534. PubMed ID: 29237435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer.
    Georgoulias VA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):18-24. PubMed ID: 11252884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.